The British Society for Gene and Cell Therapy (BSGCT) Annual Conference is one of the UK’s leading forums for scientific exchange in advanced therapy development. Bringing together researchers, clinicians, industry innovators, and regulatory thinkers, the 2026 meeting will spotlight cutting‑edge progress in gene and cell therapy, translational research, and enabling technologies that support the next generation of advanced therapy medicinal products (ATMPs).

Touchlight attendees will be on site ready to talk with innovators seeking faster, safer, and more scalable DNA solutions for advanced therapies. As companies increasingly evaluate new approaches to gene editing, regulatory readiness, and manufacturing efficiency, dbDNA™ offers a next‑generation alternative to plasmid DNA that aligns with many of the conference’s core scientific and translational themes.

Interested in next‑generation DNA manufacturing? Request a meeting with a Touchlight expert at BSGCT 2026 to explore how dbDNA™ can support your upcoming programs.

Touchlight Attendees